Concepts (124)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hearing Loss | 4 | 2017 | 54 | 0.570 |
Why?
|
| Deafness | 3 | 2017 | 36 | 0.560 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2017 | 7 | 0.520 |
Why?
|
| Spiral Ganglion | 2 | 2017 | 6 | 0.510 |
Why?
|
| Cochlear Implants | 2 | 2017 | 16 | 0.500 |
Why?
|
| Cochlear Implantation | 2 | 2017 | 12 | 0.410 |
Why?
|
| Physicians | 2 | 2009 | 477 | 0.380 |
Why?
|
| Correction of Hearing Impairment | 1 | 2012 | 3 | 0.380 |
Why?
|
| DNA Mutational Analysis | 1 | 2012 | 198 | 0.360 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2012 | 39 | 0.360 |
Why?
|
| Usher Syndromes | 1 | 2011 | 4 | 0.350 |
Why?
|
| Otorhinolaryngologic Neoplasms | 1 | 2011 | 5 | 0.350 |
Why?
|
| Leiomyosarcoma | 1 | 2011 | 9 | 0.350 |
Why?
|
| Meniere Disease | 1 | 2011 | 8 | 0.350 |
Why?
|
| Skin Neoplasms | 2 | 2012 | 408 | 0.320 |
Why?
|
| Bandages | 1 | 2010 | 16 | 0.310 |
Why?
|
| Thromboembolism | 1 | 2010 | 74 | 0.300 |
Why?
|
| Heparin | 1 | 2010 | 118 | 0.290 |
Why?
|
| Pancreatectomy | 1 | 2009 | 99 | 0.280 |
Why?
|
| Surgical Procedures, Operative | 1 | 2010 | 141 | 0.280 |
Why?
|
| Melanoma | 1 | 2012 | 333 | 0.280 |
Why?
|
| Hepatectomy | 1 | 2008 | 63 | 0.270 |
Why?
|
| Cause of Death | 1 | 2009 | 221 | 0.270 |
Why?
|
| Hemorrhage | 1 | 2010 | 285 | 0.270 |
Why?
|
| Wounds and Injuries | 1 | 2010 | 250 | 0.250 |
Why?
|
| Mutation | 2 | 2012 | 2655 | 0.250 |
Why?
|
| Liver Diseases | 1 | 2008 | 158 | 0.250 |
Why?
|
| Hearing | 2 | 2017 | 31 | 0.240 |
Why?
|
| General Surgery | 1 | 2008 | 211 | 0.230 |
Why?
|
| Hospitals | 1 | 2008 | 386 | 0.230 |
Why?
|
| Pancreatic Neoplasms | 1 | 2009 | 354 | 0.230 |
Why?
|
| Anticoagulants | 1 | 2010 | 525 | 0.230 |
Why?
|
| Phenotype | 4 | 2013 | 1230 | 0.220 |
Why?
|
| Radiotherapy, Adjuvant | 2 | 2017 | 59 | 0.220 |
Why?
|
| Hospital Mortality | 1 | 2009 | 872 | 0.210 |
Why?
|
| Audiometry, Pure-Tone | 2 | 2015 | 27 | 0.210 |
Why?
|
| Auditory Threshold | 2 | 2015 | 30 | 0.210 |
Why?
|
| Clinical Competence | 1 | 2009 | 727 | 0.210 |
Why?
|
| Genetic Testing | 3 | 2013 | 141 | 0.190 |
Why?
|
| Genetic Variation | 3 | 2017 | 392 | 0.190 |
Why?
|
| Aged | 7 | 2017 | 14949 | 0.190 |
Why?
|
| Neoplasm Staging | 2 | 2017 | 544 | 0.190 |
Why?
|
| Postoperative Complications | 1 | 2010 | 1322 | 0.180 |
Why?
|
| Middle Aged | 8 | 2017 | 18252 | 0.180 |
Why?
|
| Software | 2 | 2015 | 399 | 0.170 |
Why?
|
| Male | 10 | 2017 | 31020 | 0.160 |
Why?
|
| Retrospective Studies | 5 | 2017 | 6859 | 0.160 |
Why?
|
| Female | 10 | 2017 | 33982 | 0.150 |
Why?
|
| Humans | 15 | 2017 | 65168 | 0.140 |
Why?
|
| Survival Rate | 2 | 2012 | 843 | 0.140 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2012 | 729 | 0.140 |
Why?
|
| Salivary Ducts | 1 | 2017 | 1 | 0.130 |
Why?
|
| Carcinoma, Mucoepidermoid | 1 | 2017 | 7 | 0.130 |
Why?
|
| Adenoma, Pleomorphic | 1 | 2017 | 9 | 0.130 |
Why?
|
| Neoplasm Grading | 1 | 2017 | 94 | 0.130 |
Why?
|
| Serine Endopeptidases | 2 | 2017 | 121 | 0.120 |
Why?
|
| Connexin 26 | 2 | 2014 | 2 | 0.120 |
Why?
|
| Survival Analysis | 1 | 2017 | 576 | 0.120 |
Why?
|
| Connexins | 2 | 2014 | 9 | 0.120 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2015 | 34 | 0.110 |
Why?
|
| Acoustic Stimulation | 2 | 2012 | 62 | 0.110 |
Why?
|
| Neoplasm Proteins | 2 | 2017 | 285 | 0.110 |
Why?
|
| Treatment Outcome | 3 | 2017 | 5783 | 0.110 |
Why?
|
| Exome | 1 | 2014 | 69 | 0.110 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 5606 | 0.110 |
Why?
|
| Genomics | 2 | 2017 | 384 | 0.100 |
Why?
|
| Genome, Human | 2 | 2014 | 237 | 0.100 |
Why?
|
| Adenocarcinoma | 1 | 2017 | 365 | 0.100 |
Why?
|
| Genotype | 2 | 2013 | 673 | 0.100 |
Why?
|
| Adult | 5 | 2017 | 17331 | 0.090 |
Why?
|
| Evolution, Molecular | 1 | 2014 | 347 | 0.090 |
Why?
|
| Genes, Modifier | 1 | 2011 | 4 | 0.090 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 414 | 0.090 |
Why?
|
| Genetic Linkage | 1 | 2011 | 97 | 0.090 |
Why?
|
| Adolescent | 3 | 2017 | 6296 | 0.090 |
Why?
|
| Lymphatic Metastasis | 1 | 2011 | 90 | 0.090 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2011 | 32 | 0.090 |
Why?
|
| Analysis of Variance | 1 | 2012 | 602 | 0.090 |
Why?
|
| Polymorphism, Genetic | 1 | 2011 | 198 | 0.080 |
Why?
|
| Membrane Proteins | 2 | 2017 | 917 | 0.080 |
Why?
|
| Combined Modality Therapy | 1 | 2011 | 372 | 0.080 |
Why?
|
| Neoplasm Invasiveness | 1 | 2011 | 287 | 0.080 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 415 | 0.080 |
Why?
|
| Population Surveillance | 1 | 2011 | 210 | 0.080 |
Why?
|
| Patient Selection | 1 | 2012 | 483 | 0.080 |
Why?
|
| Case-Control Studies | 2 | 2014 | 1140 | 0.080 |
Why?
|
| Semicircular Canals | 1 | 2009 | 4 | 0.080 |
Why?
|
| Vestibular Function Tests | 1 | 2009 | 4 | 0.080 |
Why?
|
| Evoked Potentials, Auditory | 1 | 2009 | 13 | 0.080 |
Why?
|
| Vestibular Diseases | 1 | 2009 | 6 | 0.080 |
Why?
|
| Probability | 1 | 2009 | 170 | 0.070 |
Why?
|
| Confidence Intervals | 1 | 2009 | 236 | 0.070 |
Why?
|
| Health Care Surveys | 1 | 2009 | 287 | 0.070 |
Why?
|
| Carrier Proteins | 1 | 2012 | 714 | 0.070 |
Why?
|
| Severity of Illness Index | 1 | 2012 | 1554 | 0.060 |
Why?
|
| Child | 1 | 2017 | 4606 | 0.060 |
Why?
|
| Registries | 1 | 2011 | 923 | 0.060 |
Why?
|
| Age Factors | 1 | 2011 | 1584 | 0.060 |
Why?
|
| Odds Ratio | 1 | 2009 | 753 | 0.060 |
Why?
|
| Young Adult | 1 | 2017 | 4811 | 0.060 |
Why?
|
| Prognosis | 1 | 2011 | 1783 | 0.060 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 1628 | 0.060 |
Why?
|
| Logistic Models | 1 | 2009 | 1269 | 0.060 |
Why?
|
| Audiometry | 2 | 2017 | 14 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 2013 | 1695 | 0.030 |
Why?
|
| Cochlea | 1 | 2017 | 17 | 0.030 |
Why?
|
| Models, Neurological | 1 | 2017 | 83 | 0.030 |
Why?
|
| Speech Perception | 1 | 2017 | 79 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2014 | 122 | 0.030 |
Why?
|
| Phylogeny | 1 | 2014 | 388 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2014 | 361 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2013 | 412 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2013 | 509 | 0.020 |
Why?
|
| Reflex, Vestibulo-Ocular | 1 | 2009 | 1 | 0.020 |
Why?
|
| Bone Conduction | 1 | 2009 | 5 | 0.020 |
Why?
|
| Neck Muscles | 1 | 2009 | 10 | 0.020 |
Why?
|
| Internet | 1 | 2013 | 468 | 0.020 |
Why?
|
| Syndrome | 1 | 2009 | 178 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2009 | 148 | 0.020 |
Why?
|
| Electromyography | 1 | 2009 | 99 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 213 | 0.020 |
Why?
|
| ROC Curve | 1 | 2009 | 292 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 2009 | 209 | 0.020 |
Why?
|
| Algorithms | 1 | 2013 | 1046 | 0.020 |
Why?
|